"Glucose" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.
| Descriptor ID |
D005947
|
| MeSH Number(s) |
D09.947.875.359.448
|
| Concept/Terms |
Glucose- Glucose
- D-Glucose
- D Glucose
- Dextrose
|
Below are MeSH descriptors whose meaning is more general than "Glucose".
Below are MeSH descriptors whose meaning is more specific than "Glucose".
This graph shows the total number of publications written about "Glucose" by people in this website by year, and whether "Glucose" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 5 | 3 | 8 |
| 1994 | 5 | 4 | 9 |
| 1995 | 4 | 9 | 13 |
| 1996 | 1 | 10 | 11 |
| 1997 | 8 | 8 | 16 |
| 1998 | 4 | 12 | 16 |
| 1999 | 5 | 6 | 11 |
| 2000 | 1 | 7 | 8 |
| 2001 | 6 | 10 | 16 |
| 2002 | 5 | 7 | 12 |
| 2003 | 6 | 8 | 14 |
| 2004 | 4 | 14 | 18 |
| 2005 | 9 | 5 | 14 |
| 2006 | 3 | 8 | 11 |
| 2007 | 7 | 9 | 16 |
| 2008 | 2 | 12 | 14 |
| 2009 | 5 | 14 | 19 |
| 2010 | 12 | 12 | 24 |
| 2011 | 6 | 6 | 12 |
| 2012 | 7 | 13 | 20 |
| 2013 | 6 | 8 | 14 |
| 2014 | 4 | 6 | 10 |
| 2015 | 5 | 9 | 14 |
| 2016 | 3 | 6 | 9 |
| 2017 | 5 | 6 | 11 |
| 2018 | 4 | 9 | 13 |
| 2019 | 6 | 8 | 14 |
| 2020 | 5 | 8 | 13 |
| 2021 | 2 | 6 | 8 |
| 2022 | 1 | 16 | 17 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glucose" by people in Profiles.
-
Palmitoylation couples insulin hypersecretion with ? cell failure in diabetes. Cell Metab. 2023 02 07; 35(2):332-344.e7.
-
Dietary fat intake is associated with insulin resistance and an adverse vascular profile in patients with T1D: a pooled analysis. Eur J Nutr. 2023 Apr; 62(3):1231-1238.
-
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis. Diabetes Care. 2022 12 01; 45(12):2991-2998.
-
Glucose Testing in an Index Pregnancy and Outcomes in a Subsequent Pregnancy: Implications for Screening and a Novel Risk Calculator. Am J Perinatol. 2023 02; 40(3):243-249.
-
Glucose Infusion Induced Change in Intracellular pH and Its Relationship with Tumor Glycolysis in a C6 Rat Model of Glioblastoma. Mol Imaging Biol. 2023 Apr; 25(2):271-282.
-
The changing trajectory of diabetic kidney disease. Curr Opin Nephrol Hypertens. 2023 01 01; 32(1):98-102.
-
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study. Ann Intern Med. 2022 10; 175(10):1392-1400.
-
Diabetes management in chronic kidney disease: a?consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2022 11; 102(5):974-989.
-
A physical activity-intensity driven glycemic model for type 1 diabetes. Comput Methods Programs Biomed. 2022 Nov; 226:107153.
-
Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy. Eur Heart J. 2022 09 21; 43(36):3477-3489.